Aurobindo Pharma Recalls 2 Lots Of Lisinopril
DSIJ Intelligence / 07 Jun 2013
Aurobindo Pharma has recalled two lots of Lisinopril. The recall however is not significant.
Aurobindo Pharma has said that it has recalled 2 lots of Lisinopril tablets in the USA. Lisinopril is used in the treatment of ear failure and hypertension. The drug recall is of class 3 type and is at the distribution level. The company told us that these 2 lots have not reached the patients and hence no adverse impact is expected. They are recalled due to a labelling error (wrong printing of the drug strengths). The company sees no impact on its revenues. We remain bullish on the stock and would advise investors to hold their position in the stock.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.